Fresenius SE is exploring steps to relinquish control of dialysis subsidiary Fresenius Medical Care AG, the German healthcare company said.
(Bloomberg) — Fresenius SE is exploring steps to relinquish control of dialysis subsidiary Fresenius Medical Care AG, the German healthcare company said.
Chief Executive Officer Michael Sen is discussing such a move with the Else Kroener-Fresenius Stiftung, the company’s dominant shareholder, which is in favor of the plan, according to a statement.
The move comes after Bloomberg reported in October that shareholder activist firm Elliott Investment Management had taken a stake in Fresenius SE, seeking steps to untangle the sprawling health-care company.
More stories like this are available on bloomberg.com
©2023 Bloomberg L.P.